Fred Hutch statement on FDA’s CAR T-cell decision – Newswise (press release)
|
Fred Hutch statement on FDA’s CAR T-cell decision
Newswise (press release) “While the Food and Drug Administration’s first approval of a CAR T-cell therapy impacted a relatively small number of pediatric and young adult patients, today’s decision opens the door for a cellular immunotherapy to treat adults with aggressive … |
LA Daily News |
Cascade of costs could push new gene therapy above $1 million per patient
LA Daily News Outrage over the high cost of cancer care has focused on skyrocketing drug prices, including the $475,000 price tag for the country’s first gene therapy, Novartis’ Kymriah, a leukemia treatment approved in August. But the total costs of Kymriah and the … |
KCTV Kansas City |
Tooth banking: Is the next wave in stem cell treatment right for you?
KCTV Kansas City For example, if your child or family member turned up with some sort of blood cancer, which is a common reason to turn to stem cell storage, Burgert says you won’t get any help from banked teeth. “Those stem cells that can be extracted from teeth are … |